Understanding cardiovascular and thromboembolic events in patients with von Willebrand disease in the French West

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the frequency and characteristics of arterial and venous thromboembolic events, as well as atrial fibrillation, in adult patients with von Willebrand disease in the French West. It will utilize a retrospective multicenter approach, analyzing data from patients who have experienced thrombotic events while being treated at designated medical centers. The study seeks to fill the gap in existing literature regarding the management of thrombotic risks in this population, given their unique bleeding risk profile.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Von Willebrand disease
* Adult
* Followed-up in a reference center of West of France (Caen, Brest, Nantes, Rennes, Le Mans, Angers)
* Consented to be included in BERHLINGO database
* Have presented a thrombotic and/or embolic event or cardiovascular disease including deep vein thrombosis, pulmonary embolism, ischemic stroke, transient ischemic attack, acute coronary syndrome, acute limb ischemia or angina or obliterating arteriopathy of the lower limbs, atrial fibrillation.
* Have not expressed their opposition

Exclusion Criteria:

* \- Expression of opposition
* Acquired von Willebrand syndrome
* Patients under legal protection
* Minor

Where it's running

• CHU de Brest
  Brest, France Recruiting
• CHU d'Angers
  Angers, France Not yet recruiting
• CHU de Caen
  Caen, France Not yet recruiting
• CH le MANS
  Le Mans, France Not yet recruiting
• CHU de Nantes
  Nantes, France Not yet recruiting
• CHU de Rennes
  Rennes, France Not yet recruiting

Study contacts

• Study coordinator: Brigitte PAN PETESCH
• Email: brigitte.pan-petesch@chu-brest.fr
• Phone: 02.98.22.36.50

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ATHNdataset registry for people with bleeding and clotting disorders

  This registry collects health, treatment, and patient-reported information from people with bleeding and clotting disorders seen at ATHN-affiliated centers to help improve care and outcomes.

  Recruiting American Thrombosis and Hemostasis Network · Hickory, North Carolina · NCT06820515

• Prophylactic treatment for heavy menstrual bleeding in women with von Willebrand disease

  This study tests if a new treatment can help women with von Willebrand disease who have heavy menstrual bleeding feel better during their periods.

  Recruiting at 2 sites Phase 3 Unity Health Toronto · Kingston, Ontario and 1 other locations · NCT06205095

• Progestin options for heavy periods in young people with inherited bleeding disorders

  This project will test two progestin menstrual treatments—a levonorgestrel IUD and daily norethindrone acetate—in adolescents and young adults (ages 10–24) with inherited bleeding disorders to see which better reduces heavy menstrual bleeding over six months.

  Recruiting at 6 sites Oregon Health and Science University · Palo Alto, California and 7 other locations · NCT05916469

• Evaluating VGA039 in Healthy Volunteers and Patients with Von Willebrand Disease

  This study is testing a new treatment called VGA039 to see if it is safe and effective for healthy people and those with von Willebrand Disease.

  Recruiting at 24 sites Phase 1/2 Vega Therapeutics, Inc · Los Angeles, California and 24 other locations · NCT05776069

• Long-term observation of non-cancer blood disorders

  This study is tracking people with blood disorders like hemophilia and thrombosis for at least 15 years to see how their conditions change over time and gather useful information for doctors and researchers.

  Recruiting at 74 sites American Thrombosis and Hemostasis Network · Phoenix, Arizona and 75 other locations · NCT04398628

• Managing von Willebrand Disease in Pregnant Women

  This study is testing if giving a treatment to boost von Willebrand factor levels in pregnant women with von Willebrand disease can help prevent heavy bleeding after delivery.

  Recruiting at 10 sites University of Washington · Aurora, Colorado and 10 other locations · NCT04146376

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.